Search Results for compound
Searching compound for Pyrazole-1-alanine returned 36219 results.
Displaying compounds 11776 - 11800 of 36219 in total
FDB001979
147-94-4
4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one
Matched synonyms: … 1-Arabinofuranosylcytosine ... 1-beta-D-Arabinosylcytosine ... 1-b-D-Arabinofuranosylcytosine …
Matched iupac: … 4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one …
Matched description: … .; Cytosine arabinoside is an antimetabolic agent with the chemical name of 1? …
Matched iupac: … 4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one …
Matched description: … .; Cytosine arabinoside is an antimetabolic agent with the chemical name of 1? …
(2S)-1-hydroxy-3-(icosa-5,8,11-trienoyloxy)propan-2-yl icosa-5,8,11-trienoate
Matched iupac: … (2S)-1-hydroxy-3-(icosa-5,8,11-trienoyloxy)propan-2-yl icosa-5,8,11-trienoate …
Matched description: … Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 ... DG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/0:0), in particular, consists of two chains of mead acid at the C-1 ... diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 …
Matched description: … Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 ... DG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/0:0), in particular, consists of two chains of mead acid at the C-1 ... diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 …
(2S)-1-hydroxy-3-(icosa-8,11,14,17-tetraenoyloxy)propan-2-yl icosa-8,11,14,17-tetraenoate
Matched iupac: … (2S)-1-hydroxy-3-(icosa-8,11,14,17-tetraenoyloxy)propan-2-yl icosa-8,11,14,17-tetraenoate …
Matched description: … Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 ... /20:4(8Z,11Z,14Z,17Z)/0:0), in particular, consists of two chains of eicsoatetraenoic acid at the C-1 ... diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 …
Matched description: … Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 ... /20:4(8Z,11Z,14Z,17Z)/0:0), in particular, consists of two chains of eicsoatetraenoic acid at the C-1 ... diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 …
(2S)-3-hydroxy-2-(octadecanoyloxy)propyl docosanoate
Matched synonyms: … 1-behenoyl-2-stearoyl-sn-glycerol …
Matched description: … Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 ... DG(22:0/18:0/0:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain ... diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 …
Matched description: … Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 ... DG(22:0/18:0/0:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain ... diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 …
(2S)-3-hydroxy-2-(icosanoyloxy)propyl docosa-13,16-dienoate
Matched synonyms: … 1-docosadienoyl-2-arachidonyl-sn-glycerol …
Matched description: … Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 ... DG(22:2(13Z,16Z)/20:0/0:0), in particular, consists of one chain of docosadienoic acid at the C-1 position ... diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 …
Matched description: … Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 ... DG(22:2(13Z,16Z)/20:0/0:0), in particular, consists of one chain of docosadienoic acid at the C-1 position ... diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 …
(2S)-1-(docosa-7,10,13,16,19-pentaenoyloxy)-3-hydroxypropan-2-yl docosa-7,10,13,16,19-pentaenoate
Matched iupac: … (2S)-1-(docosa-7,10,13,16,19-pentaenoyloxy)-3-hydroxypropan-2-yl docosa-7,10,13,16,19-pentaenoate …
Matched description: … Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 ... 5(7Z,10Z,13Z,16Z,19Z)/0:0), in particular, consists of two chains of docosapentaenoic acid at the C-1 ... diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 …
Matched description: … Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 ... 5(7Z,10Z,13Z,16Z,19Z)/0:0), in particular, consists of two chains of docosapentaenoic acid at the C-1 ... diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 …
FDB014497
19890-00-7
6,6-dimethyl-2-methylidenebicyclo[3.1.1]heptan-3-one
Matched synonyms: … 2-chloro-3-ethoxy-N-(1-phenylethyl)-1-propanamine …
FDB017774
76265-24-2
{[(E)-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}hept-6-en-1-ylidene)amino]oxy}sulfonic acid
Matched synonyms: … 1-Thio-b-D-glucopyranose 1-[N-(sulfooxy)-6-heptenimidate] …
Matched iupac: … {[(E)-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}hept-6-en-1-ylidene)amino]oxy}sulfonic …
Matched iupac: … {[(E)-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}hept-6-en-1-ylidene)amino]oxy}sulfonic …
FDB018309
124596-89-0
2-[3,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one
Matched iupac: … -2H-1-benzopyran-4-one ... 2-[3,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)-3,4-dihydro …
FDB014466
4573-50-6
(6S)-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-one
Matched synonyms: … (6R)-3-Methyl-6-(1-methylethyl)-2-cyclohexen-1-one ... (6R)-6-Isopropyl-3-methylcyclohex-2-en-1-one ... (R)-6-(Isopropyl)-3-methylcyclohex-2-en-1-one …
Matched iupac: … (6S)-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-one …
Matched iupac: … (6S)-3-methyl-6-(propan-2-yl)cyclohex-2-en-1-one …
FDB012452
624-41-9
2-methylbutyl acetate
Matched synonyms: … 1-Butanol, 2-methyl-, 1-acetate ... 2-Methyl-1-butyl acetate ... 2-Methyl-1-butanol acetate …
FDB016121
693-80-1
(9E)-octadec-9-en-1-yl acetate
Matched synonyms: … 9-Octadecen-1-yl acetate ... 9Z-Octadecen-1-yl acetate ... Acetate(Z)-9-octadecen-1-ol …
Matched iupac: … (9E)-octadec-9-en-1-yl acetate …
Matched iupac: … (9E)-octadec-9-en-1-yl acetate …
FDB023069
2625-49-2
2-(1-methyl-1H-imidazol-4-yl)acetic acid
Matched synonyms: … 1-Methyl-4-imidazoleacetate ... 1-methyl-1H-Imidazole-4-acetate ... 1-Methylimidazole-4-acetate …
Matched iupac: … 2-(1-methyl-1H-imidazol-4-yl)acetic acid …
Matched iupac: … 2-(1-methyl-1H-imidazol-4-yl)acetic acid …
FDB013481
223744-29-4
2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E,19E)-3,7,12,16,20,24-hexamethylpentacosa-1,3,5,7,9,11,13,15,17,19,23-undecaen-1-yl]-3-(2-hydroxypropan-2-yl)-1-methylcyclopentan-1-ol
Matched iupac: … yl]-3-(2-hydroxypropan-2-yl)-1-methylcyclopentan-1-ol ... 7E,9E,11E,13E,15E,17E,19E)-3,7,12,16,20,24-hexamethylpentacosa-1,3,5,7,9,11,13,15,17,19,23-undecaen-1- …
FDB001654
348633-39-6
3-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one
Matched iupac: … -2H-1-benzopyran-4-one ... 3-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)-3,4-dihydro …
FDB013294
126176-79-2
2-{2-[1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propan-2-yl]-4-[(1Z)-3-hydroxyprop-1-en-1-yl]-6-methoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
Matched iupac: … 2-{2-[1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propan-2-yl]-4-[(1Z)-3-hydroxyprop-1-en-1-yl]-6-methoxyphenoxy …
FDB015891
28368-01-6
3-[(2E,4Z,6E,8E,10E,12E,14E,16Z,18E)-19-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaenoyl]-3,4,4-trimethylcyclopentan-1-one
Matched iupac: … 3-[(2E,4Z,6E,8E,10E,12E,14E,16Z,18E)-19-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-4,8,13,17-tetramethylnonadeca ... -2,4,6,8,10,12,14,16,18-nonaenoyl]-3,4,4-trimethylcyclopentan-1-one …
FDB018126
217650-81-2
2-(hydroxymethyl)-6-{4-[3-(hydroxymethyl)-5-[(1E)-3-hydroxyprop-1-en-1-yl]-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2,6-dimethoxyphenoxy}oxane-3,4,5-triol
Matched iupac: … 2-(hydroxymethyl)-6-{4-[3-(hydroxymethyl)-5-[(1E)-3-hydroxyprop-1-en-1-yl]-7-methoxy-2,3-dihydro-1-benzofuran …
FDB019355
121795-66-2
1-[5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyloxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-8-yl]-3-(2,4,6-trihydroxyphenyl)-1-(3,4,5-trihydroxyphenyl)propan-2-yl 3,4,5-trihydroxybenzoate
Matched iupac: … 1-[5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyloxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran ... -8-yl]-3-(2,4,6-trihydroxyphenyl)-1-(3,4,5-trihydroxyphenyl)propan-2-yl 3,4,5-trihydroxybenzoate …
FDB020427
107870-87-1
2-(hydroxymethyl)-6-{4-[3-(hydroxymethyl)-5-[(1Z)-3-hydroxyprop-1-en-1-yl]-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy}oxane-3,4,5-triol
Matched iupac: … 2-(hydroxymethyl)-6-{4-[3-(hydroxymethyl)-5-[(1Z)-3-hydroxyprop-1-en-1-yl]-7-methoxy-2,3-dihydro-1-benzofuran …
(2S,4S,5R)-2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-octadecanamidooctadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-{[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched description: … and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn ... site of binding for both Cholera toxin and E. coli heat-labile enterotoxin (Traveller's diarrhea).[1] …
(2S,4S,5R)-2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-icosanamidooctadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-{[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched description: … and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn ... site of binding for both Cholera toxin and E. coli heat-labile enterotoxin (Traveller's diarrhea).[1] …
(2S,4S,5R)-2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-tricosanamidooctadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-{[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched description: … and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] ... In all Gangliosides, the ceramide is linked through its C-1 to a beta-glucosyl residue, which, in turn ... site of binding for both Cholera toxin and E. coli heat-labile enterotoxin (Traveller's diarrhea).[1] …